Cancer immunotherapy: moving beyond current vaccines
Steven A. Rosenberg, James Chih-Hsin Yang, Nicholas P. Restifo · Nature Medicine · 2004
Cited by 2,972 works. doi:10.1038/nm1100
Authors
References
- New Guidelines to Evaluate the Response to Treatment in Solid Tumors
- Reporting results of cancer treatment
- Signaling by intrathymic cytokines, not T cell antigen receptors, specifies CD8 lineage choice and promotes the differentiation of cytotoxic-lineage T cells
- Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases
- Measuring Response in Solid Tumors: Unidimensional Versus Bidimensional Measurement
- Toll-Like Receptors
- Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma
- Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells
- Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
- Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma